Two new medications, called lecanemab and donanemab, have shown success in clinical trials in slowing down Alzheimer’s disease. These are known as disease-modifying treatments and have been licensed ...

Stimulant medications are considered the first-line treatment for ADHD for some very good reasons. Here are 6 things to know about stimulant medications in ADHD. Attention Deficit Hyperactivity ...

If your symptoms are serious or your doctor thinks something else is causing them, they might recommend a prescription medicine. Most people don't need any kind of treatment for mild cold symptoms.

But now, a new study finds that taking these medications may lower your risk of developing a host of different health issues, including dementia. Of course, it isn't all positive. The scientists ...

Third Alzheimer’s drug approved The U.S. Food and Drug Administration approved the new drug donanemab (brand name Kisunla) in July, giving patients more treatment options. This was the third new ...

Beloved actress Pauline Quirke, renowned for her role as Sharon Theodopolopodous in the iconic sitcom “Birds of a Feather,” has retired from acting following a dementia diagnosis. Her husband ...

Dr TR Msigwa, a Tanzanian innovator and the founder of the 4A9 African Trust Clinic, is redefining the battle against HIV/AIDS with his groundbreaking herbal treatment, 4A9. Celebrating its 30th year ...

Treatment for sleep apnea aims to improve your breathing during sleep and reduce the risk of underlying health concerns. Common options include CPAP machines, oral devices, and lifestyle measures ...

Mass General Brigham “One of the main limitations in the field of Alzheimer’s disease research and treatment is that it is extremely difficult to design medications that can pass the blood ...

One of the main limitations in the field of Alzheimer's disease research and treatment is that it is extremely difficult to design medications that can pass the blood-brain barrier-but Xenon gas does.

Xenon gas emerges as a promising treatment for Alzheimer’s, showing benefits in preclinical tests such as reducing brain atrophy and enhancing neuron protection, with human trials starting soon. A ...